|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0002823,
umls-concept:C0008976,
umls-concept:C0038454,
umls-concept:C0087111,
umls-concept:C0205178,
umls-concept:C0205548,
umls-concept:C0282440,
umls-concept:C0348016,
umls-concept:C0805732,
umls-concept:C0948008,
umls-concept:C1096777,
umls-concept:C1335960,
umls-concept:C1366753,
umls-concept:C1548425,
umls-concept:C2603343
|
|
pubmed:issue |
18
|
|
pubmed:dateCreated |
2000-5-18
|
|
pubmed:abstractText |
Approved treatment options for acute ischemic stroke in the United States and Canada are limited at present to intravenous tissue-type plasminogen activator, but bleeding complications, including intracranial hemorrhage, are a recognized complication.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
May
|
|
pubmed:issn |
0098-7484
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
10
|
|
pubmed:volume |
283
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
2395-403
|
|
pubmed:dateRevised |
2007-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:10815082-Ancrod,
pubmed-meshheading:10815082-Brain Ischemia,
pubmed-meshheading:10815082-Double-Blind Method,
pubmed-meshheading:10815082-Female,
pubmed-meshheading:10815082-Fibrinogen,
pubmed-meshheading:10815082-Fibrinolytic Agents,
pubmed-meshheading:10815082-Humans,
pubmed-meshheading:10815082-Infusions, Intravenous,
pubmed-meshheading:10815082-Logistic Models,
pubmed-meshheading:10815082-Male,
pubmed-meshheading:10815082-Middle Aged,
pubmed-meshheading:10815082-Risk,
pubmed-meshheading:10815082-Stroke,
pubmed-meshheading:10815082-Survival Analysis,
pubmed-meshheading:10815082-Time Factors
|
|
pubmed:year |
2000
|
|
pubmed:articleTitle |
Intravenous ancrod for treatment of acute ischemic stroke: the STAT study: a randomized controlled trial. Stroke Treatment with Ancrod Trial.
|
|
pubmed:affiliation |
Division of Neurology, University of Texas Health Science Center, San Antonio 78284-7883, USA. sherman@uthscsa.edu
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
